Changes to drug patent rules could affect India's vast generic medicine industry, drive up costs

Amendments to the Patent Rules grant more power to patent holders and may lead to an increase in the cost of treatment of critical diseases.

Related Keywords

Mumbai ,Maharashtra ,India ,South Africa ,Japan ,China ,South African ,Japanese ,Nandita Venkatesan ,Biswajit Dhar ,Phumeza Tisile ,Leena Menghaney ,Indira Gandhi ,Claudia Martinez ,Paul Barooah ,Supreme Court ,Frontieres Access Campaign ,World Health Assembly ,Indian Drug Manufacturer Association ,Ministry Of Commerce ,Global Drug Facility ,Patent Rules ,Global Intellectual Property Advisor ,Frontieres Access ,Swaraj Paul ,Indian Controller General ,Patents Act ,Trade Related Aspects ,Intellectual Property Rights ,Medicine Foundation ,Biosimilar Medicines ,Health ,Rug Patent Rules ,India Generic Drugs ,Ndia Generic Drug Manufacturers ,Ndia Generic Medicine ,Eneric Drugs Patent ,Edical Patent Rules India ,Rug Patent India ,Harma Patent India ,